Showing 105 results

Filters Content type: News, Editors' picks, About HIV Topic: Treatment simplification strategies

Research into HIV treatment strategies in which the number of antiretroviral drugs or frequency of dosing is reduced. Some dual therapy regimens have proven to be safe and effective.

HIV treatment

Top 10 HIV Clinical Developments of 2017

Editor's pick
The Body Pro
19 November 2017
New & experimental HIV treatments

Boosted darunavir plus lamivudine matches three-drug regimen

News
8 August 2017
New & experimental HIV treatments

The 2017 Pipeline Report

Editor's pick
Treatment Action Group
19 July 2017
New & experimental HIV treatments

ViiV Healthcare Files Regulatory Submissions for First Two-Drug HIV Maintenance Regimen

Editor's pick
ViiV
2 June 2017
New & experimental HIV treatments

Dolutegravir monotherapy fails to maintain HIV viral suppression, but dolutegravir + lamivudine looks good

News
9 March 2017
Treatment simplification strategies

Dual antiretroviral regimen maintains durable HIV suppression after switch

News
15 February 2017
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
New & experimental HIV treatments

Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen

Editor's pick
Janssen press release
20 December 2016
Treatment simplification strategies

Four days on, three days off HIV treatment controls viral load in French pilot study

News
3 November 2016
Treatment simplification strategies

Darunavir/ritonavir & lamivudine matches triple-drug therapy

News
31 October 2016
Pharmaceutical industry

Glaxo Bets It Can Shake Up HIV Treatment

Editor's pick
Wall Street Journal
30 August 2016
New & experimental HIV treatments

ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining dolutegravir and lamivudine for HIV-1 treatment

Editor's pick
ViiV press release
16 August 2016
New & experimental HIV treatments

Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment

News
25 July 2016
New & experimental HIV treatments

The HIV Treatment Pipeline

Editor's pick
Poz
28 June 2016
Treatment simplification strategies

Two-drug ART with dolutegravir-lamivudine would be cost-effective and achieve substantial cash savings

News
17 December 2015
New & experimental HIV treatments

Two-drug maintenance therapy keeps viral load suppressed and may even have advantages over traditional ART

News
30 November 2015
Treatment simplification strategies

Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?

News
23 October 2015
Pharmaceutical industry

GSK takes on Gilead with new two-drug HIV treatments

Editor's pick
Reuters
22 September 2015
Treatment simplification strategies

Week-on, weekend-off treatment controls viral load in young people

News
25 February 2015
New & experimental HIV treatments

Novel two-drug maintenance combination works at least as well as triple therapy: stage set for long-lasting injectable formulation

News
8 March 2014
Starting treatment

Dual therapy with Kaletra and 3TC works well regardless of viral load

News
20 October 2013
New & experimental HIV treatments

HIV Dual Therapy Matches Standard Triple Cocktail

Editor's pick
MedPage Today
19 October 2013
New & experimental HIV treatments

MODERN Study Stopped: An NRTI-Sparing, Two-Drug Initial Regimen Disappoints Again

Editor's pick
NEJM Journal Watch
17 October 2013
Treatment simplification strategies

PI monotherapy for HIV — an idea whose time has passed?

Editor's pick
Journal Watch
5 December 2012